Sort
130,381 grants matching “hiv”
The Role of Uncultivated Bacteria in Bacterial Vaginosis
$787,287David Neal Fredricks · Fred Hutchinson Cancer Research Center · R01 · FY2012 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$787,267Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2016 · AI
Mechanisms Blocking HIV-1 Superinfection
$787,256J. David Gladstone Institutes · R01 · FY2004 · AI
PS04-012. HIV PREVENTION PROJECTS
$787,249Sharon G Renter · Wyoming State Department Of Health · U62 · FY2007 · PS
PS10-1001, HIV PREVENTION PROJECTS
$787,249Robert Johnston · Wyoming State Department Of Health · U62 · FY2011 · PS
Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM
$787,242Trace S Kershaw · Yale University · R01 · FY2018 · HD
PUERTO RICO DRUG ABUSE RESEARCH DEVELOPMENT PROGRAM
$787,221Universidad Central Del Caribe · R24 · FY2002 · DA
Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use
$787,220Suzette V Glasner-Edwards · University Of California Los Angeles · R33 · FY2022 · AT
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
$787,163Curt G Beckwith · Miriam Hospital · R01 · FY2014 · DA
Chemoprophylaxis and HIV Host Interactions
$787,145Robert M. Grant · J. David Gladstone Institutes · R01 · FY2006 · AI
PUBLIC HIV DRUG RESISTANCE DATABASE
$787,117Robert W Shafer · Stanford University · R01 · FY2014 · AI
Contribution of CD8 T cells in Controlling Tuberculosis
$787,116Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R56 · FY2018 · AI
ANTIBODY EFFECTOR FUNCTION IN PROTECTION AGAINST HIV-1
$787,069Dennis R. Burton · Scripps Research Institute, The · R01 · FY2006 · AI
Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria
$787,015Lifang Hou · Northwestern University At Chicago · U54 · FY2021 · CA
Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy
$786,987Jennifer Manuzak · Tulane University Of Louisiana · R01 · FY2025 · HD
Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening
$786,979Britt Skaathun · University Of California, San Diego · R37 · FY2025 · DA
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
$786,968Peter W Hunt · University Of California, San Francisco · R01 · FY2017 · AI
Are Ending the HIV Epidemic goals attainable across race/ethnic groups, risk groups, and settings?
$786,943Ronald Scott Braithwaite · New York University School Of Medicine · R01 · FY2025 · AA
Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates
$786,931Guido Silvestri · Case Western Reserve University · P01 · FY2009 · AI
Chemokine Modulation During SIV Infection & AIDS
$786,852Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
Strategies for inducing bnAbs against QNES by infection with SHIVs
$786,836Shiu-Lok Hu · Rbhs-New Jersey Medical School · P01 · FY2014 · AI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women
$786,802Jenell S Coleman · Johns Hopkins University · R01 · FY2024 · MH
Identifying Optimal Treatment Strategies for Tuberculosis Treatment
$786,787Radojka Savic · University Of California, San Francisco · R01 · FY2019 · AI
PRIME: PrEP Intervention for people who Inject MEthamphetamine
$786,761Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2020 · DA
HERPESVIRUS-ASSOCIATED MALIGNANCIES IN HIV PATIENTS
$786,718Johns Hopkins University · P01 · FY2001 · CA